Insiders

04-30 GSK plc: A beat isn't enough; markets expected an outlook upgrade Alphavalue
03-09 GSK plc Appoints Elizabeth McKee Anderson as Member of the Corporate Responsibility Committee, Effective March 9, 2026 CI
02-20 GSK non-executive director buys nearly GBP75,000 in shares AN
02-17 Berenberg Says GSK 'Best Performer' in Pharmaceutical Sector; Price Target Up MT
02-06 GSK Chair Jonathan Symonds buys GBP53,000 in shares AN
02-04 GSK optimistic for 2026 after fourth-quarter results beat forecast AN
02-04 GSK's Specialty Medicines Drive Solid Results DJ
02-04 GSK forecasts slower sales growth in 2026 RE
02-04 GSK eyes sharper, faster drug development as new CEO signals growth plan RE
02-02 GSK cutting jobs in UK and US as part of ongoing R&D changes AN
01-08 GSK plc Appoints Luke Victor Miels as Director, Effective January 1, 2026 CI
01-05 GSK PLC Announces Termination of Director Appointment of Emma Natasha Walmsley, Effective December 31, 2025 CI
12-30 GSK PLC outlook improves amid merger speculation Alphavalue
29/10/25 GSK lifts sales and profit outlook as Specialty Medicines unit shines AN
29/09/25 GSK Taps Miels as CEO With Walmsley Stepping Down MT
29/09/25 GSK Names Chief Commercial Officer as CEO Designate MT
29/09/25 GSK plc Announces Board Changes CI
29/09/25 Gsk plc Announces CEO Changes CI
29/09/25 GSK Names Luke Miels CEO Designate MT
29/09/25 Luke Miels appointed CEO of GSK from January 1, 2026 Zonebourse
29/09/25 Who is GSK's next CEO Luke Miels? RE
29/09/25 GSK commercial chief to become CEO at start of "pivotal" 2026 AN
29/09/25 GSK Names Luke Miels to Succeed CEO Emma Walmsley -- Update DJ
29/09/25 GSK Names Luke Miels to Succeed CEO Emma Walmsley DJ
29/09/25 GSK Names Chief Commercial Officer as New CEO Designate MT
No results for this search